Main Article Content


Covid-19 is a new pandemic disease, which is caused by the virus knows as Coronavirus SARS-CoV-2. It is called SARS-CoV-2 because it is genetically related to each other, but the disease is different, so the ICTV announced this name on 11 February 2020. Its common signs and symptoms are infection which includes the respiratory symptoms, the fever, the cough, the shortness of breath, and the breathing difficulties. And In all of the severe cases, the infection which can cause pneumonia, and severe acute respiratory syndrome (SARS), kidney failure and its even cause death also. It is all communicable diseases and in the Ayurvedic literature s the communicable diseases are mentioned under the Janapadoddhvamsa and the Aupasargik Ragas. Its causative agents and methods of prevention have been already clearly explained in Janapadoddhvamsa. So, to manage Janapadoddhvamsa it is advised to take the usage of Rasayana therapy, Panchkarama procedures, Sadvrit  Paalan (code of right conducts) and Aachara Rasyana it means the behavioural therapy, Dhupan Karma (Fumigation) and Vaad Chikitsa (Sound therapy). And the effort has been made to find the possible Ayurvedic comparison to the current outbreak of COVID-19. It is indicated under Pranavaha Srotasa (respiratory system) diseases in kashyap Samhita, which is based on the cardinal signs and symptoms, and the system which is involved. Also aims to provide information among the Rasayana Aushadi which can be cooperated in day to day life as an immune modulator along with Vyadhihara Chikitsa. So, the effort which is made to compile the knowledge of Janapadoddhvamsa, so, it should be applied for the betterment human life and maybe also provides the answer to the challenge of COVID-19.


COVID-19 Coronavirus Janapadoddhvamsa Panchkarma Rasayana Ayurveda

Article Details

How to Cite
Vaishnavi Bhivgade, Saroj Tirpude, Bhushan Mhaiskar, & Shweta Parwe. (2020). A Review on Janapadoddhvamsa with special reference to current scenario of COVID-19 outbreak. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 1635-1639.